Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Ligases Enzyme Market by Source (Micro-organism, Animal, Plant), by Application (Polymerase Chain Reaction, Cloning, Mutation Detection, Next Generation Sequencing, Drug Target) and by End User (Diagnostic Center Hospital, Research Institute): Global Opportunity Analysis and Industry Forecast, 2023-2032

A04308

Pages: NA

Charts: NA

Tables: NA

Enzymes are biological catalysts that accelerate the speed of chemical reactions, especially the ones that occur within the body of an organism. Ligases are a specific type of enzymes that speed up the joining of two large molecules such as DNA. These enzymes are extensively used in cloning, mutation detection, gene synthesis, and next generation sequencing. Ligases enzymes are also used for correcting dysfunctions and lack of DNA ligases in humans.

The ligases enzymes market exhibits growth, due to increase in research activities and R&D investments to develop ligases as targets for therapeutic intervention of cancer. Furthermore, increase in incidence of birth genetic disorders, and infectious diseases is expected to drive the market growth as ligases find application in detection birth mutations, and infectious diseases. This market is restricted by handling and safety issues related to enzymes and constraints pertaining to the chemical and physical properties of enzymes. The involvement of enzymes in protein engineering and growth opportunities in developing regions such as Asia-Pacific and LAMEA are projected to make way for different market growth opportunities.

The ligases enzymes market is segmented based on source, application, end user, and region. By source, it is divided into micro-organism, animal, and plant. By application, it is classified into polymerase chain reaction, cloning, mutation detection, next generation sequencing, and drug targets. By end user, the market is bifurcated into diagnostic center & hospital, and research institute. Based on region, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Spain, Italy, and Rest of Europe), Asia-Pacific (Japan, China, Singapore, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).

The key players operating in this industry include Novozymes A/S, Koninklijke DSM N.V., DowDuPont Inc., BASF SE, Advanced Enzyme Technologies Ltd., AB Enzymes GmbH, Codexis, Inc., Amano Enzyme, F. Hoffmann-La Roche Ltd., and Thermo Fisher Scientific Inc.

Key Benefits

  • The report provides a quantitative analysis of the current market and estimation that assists in identifying the current market opportunities.
  • The report contains a thorough analysis of the factors that drive and restrict the growth of the global ligases enzymes market.
  • The projections in the report are made by analyzing the current and future market trends for a period.
  • Comprehensive analysis of the geographic regions is provided, which helps elucidate region wise growth.
  • Key market players within the ligases enzyme market are profiled to understand the competitor scenario.

 Key Market Segments

  • By Source
    • Micro-organism
    • Animal
    • Plant
  • By Application
    • Polymerase Chain Reaction
    • Cloning
    • Mutation Detection
    • Next Generation Sequencing
    • Drug Target
  • By End User
    • Diagnostic Center & Hospital
    • Research Institute
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Amano Enzyme
  • Advanced Enzyme Technologies Ltd.
  • AB Enzymes GmbH
  • Codexis, Inc.
  • BASF SE
  • Koninklijke DSM N.V.
  • DowDuPont Inc.
  • Thermo Fisher Scientific Inc.
  • Novozymes A/S
  • F. Hoffmann-La Roche Ltd.

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: LIGASES ENZYME MARKET, BY SOURCE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Source

    • 4.2. Micro-organism

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Animal

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Plant

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: LIGASES ENZYME MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Polymerase Chain Reaction

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Cloning

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Mutation Detection

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Next Generation Sequencing

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Drug Target

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

  • CHAPTER 6: LIGASES ENZYME MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Diagnostic Center And Hospital

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Research Institute

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

  • CHAPTER 7: LIGASES ENZYME MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Source

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Ligases Enzyme Market

        • 7.2.6.1. Market Size and Forecast, By Source
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By End User

      • 7.2.7. Canada Ligases Enzyme Market

        • 7.2.7.1. Market Size and Forecast, By Source
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By End User

      • 7.2.8. Mexico Ligases Enzyme Market

        • 7.2.8.1. Market Size and Forecast, By Source
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By End User

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Source

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Ligases Enzyme Market

        • 7.3.6.1. Market Size and Forecast, By Source
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By End User

      • 7.3.7. Germany Ligases Enzyme Market

        • 7.3.7.1. Market Size and Forecast, By Source
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By End User

      • 7.3.8. Italy Ligases Enzyme Market

        • 7.3.8.1. Market Size and Forecast, By Source
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By End User

      • 7.3.9. Spain Ligases Enzyme Market

        • 7.3.9.1. Market Size and Forecast, By Source
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By End User

      • 7.3.10. UK Ligases Enzyme Market

        • 7.3.10.1. Market Size and Forecast, By Source
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By End User

      • 7.3.11. Russia Ligases Enzyme Market

        • 7.3.11.1. Market Size and Forecast, By Source
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By End User

      • 7.3.12. Rest Of Europe Ligases Enzyme Market

        • 7.3.12.1. Market Size and Forecast, By Source
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By End User

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Source

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Ligases Enzyme Market

        • 7.4.6.1. Market Size and Forecast, By Source
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By End User

      • 7.4.7. Japan Ligases Enzyme Market

        • 7.4.7.1. Market Size and Forecast, By Source
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By End User

      • 7.4.8. India Ligases Enzyme Market

        • 7.4.8.1. Market Size and Forecast, By Source
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By End User

      • 7.4.9. South Korea Ligases Enzyme Market

        • 7.4.9.1. Market Size and Forecast, By Source
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By End User

      • 7.4.10. Australia Ligases Enzyme Market

        • 7.4.10.1. Market Size and Forecast, By Source
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By End User

      • 7.4.11. Thailand Ligases Enzyme Market

        • 7.4.11.1. Market Size and Forecast, By Source
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By End User

      • 7.4.12. Malaysia Ligases Enzyme Market

        • 7.4.12.1. Market Size and Forecast, By Source
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By End User

      • 7.4.13. Indonesia Ligases Enzyme Market

        • 7.4.13.1. Market Size and Forecast, By Source
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By End User

      • 7.4.14. Rest of Asia Pacific Ligases Enzyme Market

        • 7.4.14.1. Market Size and Forecast, By Source
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By End User

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Source

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Ligases Enzyme Market

        • 7.5.6.1. Market Size and Forecast, By Source
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By End User

      • 7.5.7. South Africa Ligases Enzyme Market

        • 7.5.7.1. Market Size and Forecast, By Source
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By End User

      • 7.5.8. Saudi Arabia Ligases Enzyme Market

        • 7.5.8.1. Market Size and Forecast, By Source
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By End User

      • 7.5.9. UAE Ligases Enzyme Market

        • 7.5.9.1. Market Size and Forecast, By Source
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By End User

      • 7.5.10. Argentina Ligases Enzyme Market

        • 7.5.10.1. Market Size and Forecast, By Source
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By End User

      • 7.5.11. Rest of LAMEA Ligases Enzyme Market

        • 7.5.11.1. Market Size and Forecast, By Source
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By End User

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Novozymes A/S

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Koninklijke DSM N.V.

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. DowDuPont Inc.

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. BASF SE

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Advanced Enzyme Technologies Ltd.

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. AB Enzymes GmbH

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Codexis, Inc.

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Amano Enzyme

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. F. Hoffmann-La Roche Ltd.

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Thermo Fisher Scientific Inc.

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL LIGASES ENZYME MARKET, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL LIGASES ENZYME MARKET FOR MICRO-ORGANISM, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL LIGASES ENZYME MARKET FOR ANIMAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL LIGASES ENZYME MARKET FOR PLANT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL LIGASES ENZYME MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL LIGASES ENZYME MARKET FOR POLYMERASE CHAIN REACTION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL LIGASES ENZYME MARKET FOR CLONING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL LIGASES ENZYME MARKET FOR MUTATION DETECTION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL LIGASES ENZYME MARKET FOR NEXT GENERATION SEQUENCING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL LIGASES ENZYME MARKET FOR DRUG TARGET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL LIGASES ENZYME MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL LIGASES ENZYME MARKET FOR DIAGNOSTIC CENTER AND HOSPITAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL LIGASES ENZYME MARKET FOR RESEARCH INSTITUTE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL LIGASES ENZYME MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. NORTH AMERICA LIGASES ENZYME, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 19. U.S. LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 20. U.S. LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 21. U.S. LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 22. CANADA LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 23. CANADA LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 24. CANADA LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 25. MEXICO LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 26. MEXICO LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 27. MEXICO LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 28. EUROPE LIGASES ENZYME, BY REGION, 2025-2033 ($MILLION)
  • TABLE 29. EUROPE LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 30. EUROPE LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 31. EUROPE LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 32. FRANCE LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 33. FRANCE LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 34. FRANCE LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 35. GERMANY LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 36. GERMANY LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 37. GERMANY LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 38. ITALY LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 39. ITALY LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 40. ITALY LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 41. SPAIN LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 42. SPAIN LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 43. SPAIN LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 44. UK LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 45. UK LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 46. UK LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 47. RUSSIA LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 48. RUSSIA LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 49. RUSSIA LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 50. REST OF EUROPE LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 51. REST OF EUROPE LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 52. REST OF EUROPE LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 53. ASIA-PACIFIC LIGASES ENZYME, BY REGION, 2025-2033 ($MILLION)
  • TABLE 54. ASIA-PACIFIC LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 55. ASIA-PACIFIC LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 56. ASIA-PACIFIC LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 57. CHINA LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 58. CHINA LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 59. CHINA LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 60. JAPAN LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 61. JAPAN LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 62. JAPAN LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 63. INDIA LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 64. INDIA LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 65. INDIA LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 66. SOUTH KOREA LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 67. SOUTH KOREA LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 68. SOUTH KOREA LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 69. AUSTRALIA LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 70. AUSTRALIA LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 71. AUSTRALIA LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 72. THAILAND LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 73. THAILAND LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 74. THAILAND LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 75. MALAYSIA LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 76. MALAYSIA LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 77. MALAYSIA LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 78. INDONESIA LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 79. INDONESIA LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 80. INDONESIA LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 81. REST OF ASIA PACIFIC LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 82. REST OF ASIA PACIFIC LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 83. REST OF ASIA PACIFIC LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 84. LAMEA LIGASES ENZYME, BY REGION, 2025-2033 ($MILLION)
  • TABLE 85. LAMEA LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 86. LAMEA LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 87. LAMEA LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 88. BRAZIL LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 89. BRAZIL LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 90. BRAZIL LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 91. SOUTH AFRICA LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 92. SOUTH AFRICA LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 93. SOUTH AFRICA LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 94. SAUDI ARABIA LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 95. SAUDI ARABIA LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 96. SAUDI ARABIA LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 97. UAE LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 98. UAE LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 99. UAE LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 100. ARGENTINA LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 101. ARGENTINA LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 102. ARGENTINA LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 103. REST OF LAMEA LIGASES ENZYME, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 104. REST OF LAMEA LIGASES ENZYME, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 105. REST OF LAMEA LIGASES ENZYME, BY END USER, 2025-2033 ($MILLION)
  • TABLE 106. NOVOZYMES A/S: KEY EXECUTIVES
  • TABLE 107. NOVOZYMES A/S: COMPANY SNAPSHOT
  • TABLE 108. NOVOZYMES A/S: OPERATING SEGMENTS
  • TABLE 109. NOVOZYMES A/S: PRODUCT PORTFOLIO
  • TABLE 110. NOVOZYMES A/S: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 111. KONINKLIJKE DSM N.V.: KEY EXECUTIVES
  • TABLE 112. KONINKLIJKE DSM N.V.: COMPANY SNAPSHOT
  • TABLE 113. KONINKLIJKE DSM N.V.: OPERATING SEGMENTS
  • TABLE 114. KONINKLIJKE DSM N.V.: PRODUCT PORTFOLIO
  • TABLE 115. KONINKLIJKE DSM N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 116. DOWDUPONT INC.: KEY EXECUTIVES
  • TABLE 117. DOWDUPONT INC.: COMPANY SNAPSHOT
  • TABLE 118. DOWDUPONT INC.: OPERATING SEGMENTS
  • TABLE 119. DOWDUPONT INC.: PRODUCT PORTFOLIO
  • TABLE 120. DOWDUPONT INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 121. BASF SE: KEY EXECUTIVES
  • TABLE 122. BASF SE: COMPANY SNAPSHOT
  • TABLE 123. BASF SE: OPERATING SEGMENTS
  • TABLE 124. BASF SE: PRODUCT PORTFOLIO
  • TABLE 125. BASF SE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 126. ADVANCED ENZYME TECHNOLOGIES LTD.: KEY EXECUTIVES
  • TABLE 127. ADVANCED ENZYME TECHNOLOGIES LTD.: COMPANY SNAPSHOT
  • TABLE 128. ADVANCED ENZYME TECHNOLOGIES LTD.: OPERATING SEGMENTS
  • TABLE 129. ADVANCED ENZYME TECHNOLOGIES LTD.: PRODUCT PORTFOLIO
  • TABLE 130. ADVANCED ENZYME TECHNOLOGIES LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 131. AB ENZYMES GMBH: KEY EXECUTIVES
  • TABLE 132. AB ENZYMES GMBH: COMPANY SNAPSHOT
  • TABLE 133. AB ENZYMES GMBH: OPERATING SEGMENTS
  • TABLE 134. AB ENZYMES GMBH: PRODUCT PORTFOLIO
  • TABLE 135. AB ENZYMES GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 136. CODEXIS, INC.: KEY EXECUTIVES
  • TABLE 137. CODEXIS, INC.: COMPANY SNAPSHOT
  • TABLE 138. CODEXIS, INC.: OPERATING SEGMENTS
  • TABLE 139. CODEXIS, INC.: PRODUCT PORTFOLIO
  • TABLE 140. CODEXIS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 141. AMANO ENZYME: KEY EXECUTIVES
  • TABLE 142. AMANO ENZYME: COMPANY SNAPSHOT
  • TABLE 143. AMANO ENZYME: OPERATING SEGMENTS
  • TABLE 144. AMANO ENZYME: PRODUCT PORTFOLIO
  • TABLE 145. AMANO ENZYME: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 146. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
  • TABLE 147. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
  • TABLE 148. F. HOFFMANN-LA ROCHE LTD.: OPERATING SEGMENTS
  • TABLE 149. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
  • TABLE 150. F. HOFFMANN-LA ROCHE LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 151. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
  • TABLE 152. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • TABLE 153. THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
  • TABLE 154. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
  • TABLE 155. THERMO FISHER SCIENTIFIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL LIGASES ENZYME MARKET SEGMENTATION
  • FIGURE 2. GLOBAL LIGASES ENZYME MARKET
  • FIGURE 3. SEGMENTATION LIGASES ENZYME MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN LIGASES ENZYME MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALLIGASES ENZYME MARKET
  • FIGURE 11. LIGASES ENZYME MARKET SEGMENTATION, BY BY SOURCE
  • FIGURE 12. LIGASES ENZYME MARKET FOR MICRO-ORGANISM, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. LIGASES ENZYME MARKET FOR ANIMAL, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. LIGASES ENZYME MARKET FOR PLANT, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. LIGASES ENZYME MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 16. LIGASES ENZYME MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. LIGASES ENZYME MARKET FOR CLONING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. LIGASES ENZYME MARKET FOR MUTATION DETECTION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. LIGASES ENZYME MARKET FOR NEXT GENERATION SEQUENCING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. LIGASES ENZYME MARKET FOR DRUG TARGET, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. LIGASES ENZYME MARKET SEGMENTATION, BY BY END USER
  • FIGURE 22. LIGASES ENZYME MARKET FOR DIAGNOSTIC CENTER AND HOSPITAL, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. LIGASES ENZYME MARKET FOR RESEARCH INSTITUTE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 25. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 26. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 27. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 28. COMPETITIVE DASHBOARD
  • FIGURE 29. COMPETITIVE HEATMAP: LIGASES ENZYME MARKET
  • FIGURE 30. TOP PLAYER POSITIONING, 2024
  • FIGURE 31. NOVOZYMES A/S: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 32. NOVOZYMES A/S: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 33. NOVOZYMES A/S: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 34. KONINKLIJKE DSM N.V.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 35. KONINKLIJKE DSM N.V.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 36. KONINKLIJKE DSM N.V.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 37. DOWDUPONT INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 38. DOWDUPONT INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 39. DOWDUPONT INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 40. BASF SE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 41. BASF SE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 42. BASF SE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 43. ADVANCED ENZYME TECHNOLOGIES LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. ADVANCED ENZYME TECHNOLOGIES LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. ADVANCED ENZYME TECHNOLOGIES LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. AB ENZYMES GMBH: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. AB ENZYMES GMBH: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. AB ENZYMES GMBH: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. CODEXIS, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. CODEXIS, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. CODEXIS, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 52. AMANO ENZYME: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 53. AMANO ENZYME: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 54. AMANO ENZYME: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 55. F. HOFFMANN-LA ROCHE LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 56. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 57. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 58. THERMO FISHER SCIENTIFIC INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 59. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 60. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Ligases Enzyme Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved